Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $1.60, but opened at $1.50. Akso Health Group shares last traded at $1.51, with a volume of 1,175 shares trading hands.
Wall Street Analyst Weigh In
A number of analysts have weighed in on AHG shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Akso Health Group in a research report on Monday, April 20th. Wall Street Zen upgraded Akso Health Group to a “sell” rating in a research report on Saturday, May 2nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.
Read Our Latest Analysis on AHG
Akso Health Group Stock Performance
Hedge Funds Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC purchased a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 16,748 shares of the company’s stock, valued at approximately $27,000. Institutional investors and hedge funds own 1.21% of the company’s stock.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
See Also
- Five stocks we like better than Akso Health Group
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
